By the mid-1980s, heat treatment was adopted as standard, but some companies continued to export their old, unheated inventory. Cutter sold it to Taiwan, Malaysia, Hong Kong, Argentina, Japan, and Indonesia, exporting more than one hundred thousand vials of unsafe, unheated concentrate – even though by then it produced heated product, too – and earned more than $4 million. In response, Bayer officials told the New York Times that Cutter had behaved ‘responsibly, ethically and humanely’.30
